Valeo artis
The art of creating health
A modern Ukrainian pharmaceutical company engaged in the development, production, and promotion of medicines and health products.
The primary goal of Valartin Pharma LLC is to meet consumer needs for safe, effective, high-quality, and affordable medicines by implementing modern technologies and a quality assurance system at every stage of the product lifecycle.
Gastroenterology
Medications aimed at supporting gastrointestinal health, treating gastritis, peptic ulcers, heartburn, liver dysfunction, and digestion issues.
Cardiology
Products for the prevention and treatment of cardiovascular diseases, including hypertension, ischemic heart disease, and heart rhythm disorders.
Gynecology
Medications designed to support women’s health, treat hormonal imbalances, infections, and improve reproductive function.
Otolaryngology
Medications for the treatment of inflammatory processes and infections in the throat, nose, and ears, as well as for alleviating cold symptoms.
Neurology
Products aimed at supporting the health of the nervous system, treating headaches, insomnia, anxiety disorders, and other neurological conditions.
Urology
Medications for the treatment of urinary system diseases, including infections, inflammatory processes, and dysfunctions of the kidneys and bladder.
Dermatology
Medications for the treatment of skin diseases such as acne, dermatitis, psoriasis, and for general skin care.
Metabolic Therapy
Products for correcting metabolic disorders, addressing vitamin and mineral deficiencies, providing antioxidants, and supporting overall body health.
Ophthalmology
Medications for treating eye infections, inflammations, dryness, and other vision- related issues.
Immunostimulatory and Antiviral Medications
Products to boost the immune system, prevent and treat viral infections, including colds and flu.Products
Valargin PLUS
Additional source of the amino acids L-arginine and L-citrulline
PROSTAVALAR®
PROSTAVALAR – support of optimal hormonal balance in men
PRESS-CENTER
28 April 2025
